Faron Pharmaceuticals Oy (FARN.L)

GBp 175.0

(2.94%)

Operating Expenses Summary of Faron Pharmaceuticals Oy

Faron Pharmaceuticals Oy's latest annual operating expenses in 2023 was 28.56 Million EUR , up 4.17% from previous year.
Faron Pharmaceuticals Oy's latest quarterly operating expenses in 2024 Q2 was 5645.00 EUR , down 0.0% from previous quarter.
Faron Pharmaceuticals Oy reported a annual operating expenses of 27.42 Million EUR in annual operating expenses 2022, up 29.93% from previous year.
Faron Pharmaceuticals Oy reported a annual operating expenses of 21.1 Million EUR in annual operating expenses 2021, up 26.74% from previous year.
Faron Pharmaceuticals Oy reported a quarterly operating expenses of 5645.00 EUR for 2024 Q1, down -28.34% from previous quarter.
Faron Pharmaceuticals Oy reported a quarterly operating expenses of 8097.50 EUR for 2023 Q3, up 26.4% from previous quarter.

Annual Operating Expenses Chart of Faron Pharmaceuticals Oy (2023 - 2012)

Historical Annual Operating Expenses of Faron Pharmaceuticals Oy (2023 - 2012)

Year	Operating Expenses	Operating Expenses Growth
2023	28.56 Million EUR	4.17%
2022	27.42 Million EUR	29.93%
2021	21.1 Million EUR	26.74%
2020	16.65 Million EUR	27.12%
2019	13.1 Million EUR	-33.4%
2018	19.67 Million EUR	-4.79%
2017	20.65 Million EUR	106.36%
2016	10.01 Million EUR	58.13%
2015	6.33 Million EUR	265.11%
2014	1.73 Million EUR	29.4%
2013	1.34 Million EUR	-43.08%
2012	2.35 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	5645.00 EUR	0.0%
2024 Q1	5645.00 EUR	-28.34%
2023 Q3	8097.50 EUR	26.4%
2023 Q4	7878.00 EUR	-2.71%
2023 FY	29 Million EUR	5.77%
2023 Q1	6406.00 EUR	-8.51%
2023 Q2	6406.00 EUR	0.0%
2022 Q3	7002.00 EUR	4.79%
2022 Q4	7002.00 EUR	0.0%
2022 FY	27.42 Million EUR	29.93%
2022 Q1	6682.00 EUR	26.78%
2022 Q2	6682.00 EUR	0.0%
2021 Q2	5212.00 EUR	0.0%
2021 Q4	5270.50 EUR	0.0%
2021 Q3	5270.50 EUR	1.12%
2021 FY	21.1 Million EUR	26.74%
2021 Q1	5212.00 EUR	6.91%
2020 Q2	3572.00 EUR	0.0%
2020 Q1	3572.00 EUR	5.82%
2020 Q3	4875.00 EUR	36.48%
2020 FY	16.65 Million EUR	27.12%
2020 Q4	4875.00 EUR	0.0%
2019 FY	13.1 Million EUR	-33.4%
2019 Q1	3172.00 EUR	3.74%
2019 Q2	3172.00 EUR	0.0%
2019 Q3	3375.50 EUR	6.42%
2019 Q4	3375.50 EUR	0.0%
2018 FY	19.67 Million EUR	-4.79%
2018 Q4	3057.50 EUR	0.0%
2018 Q3	3057.50 EUR	-56.5%
2018 Q2	7029.00 EUR	0.0%
2018 Q1	7029.00 EUR	-6.15%
2017 Q1	3750.50 EUR	-8.66%
2017 Q2	3750.50 EUR	0.0%
2017 FY	20.65 Million EUR	106.36%
2017 Q4	7489.50 EUR	0.0%
2017 Q3	7489.50 EUR	99.69%
2016 Q2	1900.00 EUR	0.0%
2016 Q4	4106.00 EUR	0.0%
2016 FY	10.01 Million EUR	58.13%
2016 Q3	4106.00 EUR	116.11%
2016 Q1	1900.00 EUR	-1.27%
2015 FY	6.33 Million EUR	265.11%
2015 Q3	1924.50 EUR	39.76%
2015 Q4	1924.50 EUR	0.0%
2015 Q1	1377.00 EUR	194.55%
2015 Q2	1377.00 EUR	0.0%
2014 Q3	467.50 EUR	15.43%
2014 Q1	405.00 EUR	0.0%
2014 FY	1.73 Million EUR	29.4%
2014 Q4	467.50 EUR	0.0%
2014 Q2	405.00 EUR	0.0%
2013 FY	1.34 Million EUR	-43.08%
2012 FY	2.35 Million EUR	0.0%

Peer Operating Expenses Comparison of Faron Pharmaceuticals Oy

Name	Operating Expenses	Operating Expenses Difference